Loading...
XETREVK
Market cap7.99bUSD
Dec 20, Last price  
16.44EUR
1D
0.31%
1Q
-19.21%
Jan 2017
-42.07%
IPO
-48.94%
Name

Evonik Industries

Chart & Performance

D1W1MN
XETR:EVK chart
P/E
—
P/S
0.50
EPS
—
Div Yield, %
7.11%
Shrs. gr., 5y
—
Rev. gr., 5y
0.32%
Revenues
15.27b
-17.42%
14,125,000,00014,430,000,00015,873,000,00013,076,000,00013,300,000,00014,540,000,00013,629,000,00012,874,000,00012,917,000,00013,507,000,00012,732,000,00014,419,000,00015,024,000,00013,108,000,00012,199,000,00014,955,000,00018,488,000,00015,267,000,000
Net income
-465m
L
1,046,000,000876,000,000285,000,000240,000,000734,000,0001,011,000,0001,164,000,0002,054,000,000568,000,000991,000,000844,000,000717,000,000932,000,000774,000,000465,000,000746,000,000540,000,000-465,000,000
CFO
1.59b
-3.39%
1,142,000,0001,215,000,000388,000,0002,092,000,0002,075,000,0001,309,000,0001,420,000,0001,083,000,0001,066,000,0001,971,000,0001,758,000,0001,551,000,0001,704,000,0001,321,000,0001,727,000,0001,815,000,0001,650,000,0001,594,000,000
Dividend
Jun 05, 20241.17 EUR/sh
Earnings
Mar 05, 2025

Profile

Evonik Industries AG engages in the specialty chemicals business. It operates through Specialty Additives, Nutrition & Care, Smart Materials, Performance Materials, and Technology & Infrastructure segments. The Specialty Additives segment provides polyurethane additives, organically modified silicones, isophorones, epoxy curing agents, oil additives, fumed silicas, matting agents, TAA and TAA derivatives, and acetylenic diol-based surfactants for consumer goods and specialized industrial applications. The Nutrition & Care segment offers amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, animal nutrition, and healthcare products. The Smart Materials segment provides hydrogen peroxide, peracetic acid, activated nickel catalysts, precious metal powder catalysts, oil and fat hydrogenation catalysts, amorphous polyalphaolefins, polybutadienes, polyester resins, thermoplastic and reactive methacrylate resins, PEEK, polyamide 12, organosilanes, chlorosilanes, fumed silicas, fumed metal oxides, and precipitated silicas for the automotive, paints, coatings, adhesives, construction, and various other sectors. The Performance Materials segment produces polymer materials and intermediates, including butene-1, DINP, isononanol, cyanuric chloride, alkoxides, and superabsorbent for rubber, plastics, and automotive industries. The Technology & Infrastructure segment provides site management, utilities and waste management, technical, process technology, engineering, and logistics services. It operates in the Asia-Pacific, Europe, the Middle East, Africa, Central and South America, and North America. The company was founded in 1873 and is headquartered in Essen, Germany. Evonik Industries AG is a subsidiary of RAG-Stiftung.
URL
https://corporate.evonik.com
IPO date
May 01, 2013
Employees
33,357
Domiciled in
DE
Incorporated in
DE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
15,267,000
-17.42%
18,488,000
23.62%
14,955,000
22.59%
Cost of revenue
14,652,000
17,306,000
13,652,000
Unusual Expense (Income)
NOPBT
615,000
1,182,000
1,303,000
NOPBT Margin
4.03%
6.39%
8.71%
Operating Taxes
101,000
369,000
316,000
Tax Rate
16.42%
31.22%
24.25%
NOPAT
514,000
813,000
987,000
Net income
(465,000)
-186.11%
540,000
-27.61%
746,000
60.43%
Dividends
(545,000)
(545,000)
(536,000)
Dividend yield
6.32%
6.52%
4.04%
Proceeds from repurchase of equity
(4,000)
(4,000)
(3,000)
BB yield
0.05%
0.05%
0.02%
Debt
Debt current
952,000
184,000
166,000
Long-term debt
4,232,000
4,992,000
4,068,000
Deferred revenue
134,000
146,000
139,000
Other long-term liabilities
4,192,000
2,255,000
4,675,000
Net debt
3,659,000
4,042,000
3,129,000
Cash flow
Cash from operating activities
1,594,000
1,650,000
1,815,000
CAPEX
(793,000)
(865,000)
(886,000)
Cash from investing activities
(653,000)
(777,000)
(1,070,000)
Cash from financing activities
(823,000)
(672,000)
(856,000)
FCF
1,392,000
(266,000)
583,000
Balance
Cash
1,033,000
1,120,000
919,000
Long term investments
492,000
14,000
186,000
Excess cash
761,650
209,600
357,250
Stockholders' equity
8,986,000
9,893,000
8,316,000
Invested Capital
16,797,350
17,054,400
17,261,750
ROIC
3.04%
4.74%
5.77%
ROCE
3.39%
6.59%
7.14%
EV
Common stock shares outstanding
466,000
466,000
466,000
Price
18.51
3.23%
17.93
-37.02%
28.47
6.71%
Market cap
8,625,660
3.23%
8,355,380
-37.02%
13,267,020
6.71%
EV
12,360,660
12,484,380
16,591,020
EBITDA
1,713,000
2,750,000
2,376,000
EV/EBITDA
7.22
4.54
6.98
Interest
108,000
121,000
129,000
Interest/NOPBT
17.56%
10.24%
9.90%